within Pharmacolibrary.Drugs.ATC.C;

model C10AA02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.0005,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.03,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.03333333333333333,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.1,
    k12             = 150,
    k21             = 150
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C10AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Lovastatin is an HMG-CoA reductase inhibitor (statin) used to lower cholesterol and reduce cardiovascular risk. It is approved for the treatment of primary hypercholesterolemia and mixed dyslipidemia.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single oral dose administration.</p><h4>References</h4><ol><li><p>Kosoglou, T, et al., &amp; Alton, KB (2005). Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. <i>Clinical pharmacokinetics</i> 44(5) 467–494. DOI:<a href=\"https://doi.org/10.2165/00003088-200544050-00002\">10.2165/00003088-200544050-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15871634/\">https://pubmed.ncbi.nlm.nih.gov/15871634</a></p></li><li><p>Chung, JW, et al., &amp; Choi, JS (2010). Effects of lovastatin on the pharmacokinetics of nicardipine in rats. <i>Biopharmaceutics &amp; drug disposition</i> 31(7) 436–441. DOI:<a href=\"https://doi.org/10.1002/bdd.721\">10.1002/bdd.721</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20824619/\">https://pubmed.ncbi.nlm.nih.gov/20824619</a></p></li><li><p>Tornio, A, et al., &amp; Niemi, M (2015). SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid. <i>Pharmacogenetics and genomics</i> 25(8) 382–387. DOI:<a href=\"https://doi.org/10.1097/FPC.0000000000000148\">10.1097/FPC.0000000000000148</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26020121/\">https://pubmed.ncbi.nlm.nih.gov/26020121</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C10AA02;
